| | | | | | | | | | |
|
|
| Dockets Entered
On September 27, 2004
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1992S-0251
|
| Electronic Submissions; Establishment of Public Docket
|
|
|
| 1996P-0418
|
| Reduce the Precense of Salmonella Enteritidis in Shell Eggs
|
|
|
| 1997P-0197
|
| Require that warning labels about risks of salmonella enteri
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
| 1998P-0203
|
| Eliminate Forced Molting of Laying Birds
|
|
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
|
|
|
| 2000N-0504
|
| Egg Safety Action Plan
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
| 2002D-0325
|
| Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
| 2003H-0432
|
| Civil Money Penalty, Korangy Radiology Associates, PA
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
| 2004D-0371
|
| Class II Special Controls Guidance Document: Serological Reagents for the Detection of Beta-Glucan
|
|
|
| 2004N-0018
|
| Human Subject Protection; Foreign Clinical Studies Not Conducted Under an Investigational New Drug Application
|
|
|
| 2004N-0370
|
| Medical Devices; Immunology and Microbiology Devices; Classification of the Beta-Glucan Serological Assay
|
|
|
| 2004N-0408
|
| Regulatory Site Visit Training Program
|
|
|
| 2004Q-0097
|
| Qualified Health Claim: Calcium and various cancers
|
|
|
| 2004Q-0098
|
| Qualified Health Claim: Calcium and hypertension
|
|
|
| 2004Q-0099
|
| Qualified Health Claim: Calcium and menstrual disorders
|
|
|
| 2004Q-0100
|
| Qualified Health Claim: Calcium and bone fractures
|
|
|
| 2004Q-0102
|
| Qualified Health Claim: Calcium and Kidney/urinary stones
|
|
|
| 2004Q-0144
|
| Qualified Health Claim (QHC): Chromium picolinate and Diabetes
|
|
|
| 1992S-0251
|
| Electronic Submissions; Establishment of Public Docket
|
|
| M
31
|
| Content Labeling, 314.50(l), 314.94(d), 601.14(b), and 314.81(b)
|
| Vol #:
|
| 1
|
|
|
| 1996P-0418
|
| Reduce the Precense of Salmonella Enteritidis in Shell Eggs
|
|
|
| NPR
2
|
| FDA
|
| Vol #:
|
| 32
|
|
|
| 1997P-0197
|
| Require that warning labels about risks of salmonella enteri
|
|
|
| NPR
2
|
| FDA
|
| Vol #:
|
| 42
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
| EMC 4269
|
| R. Markessinis
|
| Vol #:
|
| 304
|
|
|
| 1998P-0203
|
| Eliminate Forced Molting of Laying Birds
|
|
|
| NPR
1
|
| FDA
|
| Vol #:
|
| 49
|
|
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
|
|
| | | | | | | | |
|
|
| EMC 10477
|
| K. Perez
|
| Vol #:
|
| 294
|
|
|
| EMC 10478
|
| A. Biuso
|
| Vol #:
|
| 294
|
|
|
| 2002D-0325
|
| Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
|
|
|
| EMC 187
|
| A. Boone
|
| Vol #:
|
| 3
|
|
|
| EMC 188
|
| A. Urban
|
| Vol #:
|
| 3
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
| EMC 369
|
| Dr. B. Martini
|
| Vol #:
|
| 6
|
|
|
| EMC 370
|
| Dr. B. Martini
|
| Vol #:
|
| 6
|
|
|
| 2003H-0432
|
| Civil Money Penalty, Korangy Radiology Associates, PA
|
|
|
| LET
8
|
| Korangy Radiology Association
|
| Vol #:
|
| 4
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
| EMC 390
|
| M. Collins
|
| Vol #:
|
| 9
|
|
|
| EMC 391
|
| T. Bellai
|
| Vol #:
|
| 9
|
|
|
| EMC 392
|
| M. Davin
|
| Vol #:
|
| 9
|
|
|
| EMC 393
|
| R. Gates
|
| Vol #:
|
| 9
|
|
|
| EMC 394
|
| C. Henshaw
|
| Vol #:
|
| 9
|
|
|
| EMC 395
|
| A. Feltz
|
| Vol #:
|
| 9
|
|
|
| EMC 396
|
| No signature
|
| Vol #:
|
| 9
|
|
|
| EMC 397
|
| J. Morgan
|
| Vol #:
|
| 9
|
|
|
| EMC 398
|
| S. Wilkie
|
| Vol #:
|
| 9
|
|
|
| EMC 399
|
| A. DeGregorio
|
| Vol #:
|
| 9
|
|
|
| EMC 400
|
| R. Burger, D.C., CCSP, DIBAK
|
| Vol #:
|
| 9
|
|
|
| EMC 401
|
| B. Levin
|
| Vol #:
|
| 9
|
|
|
| EMC 402
|
| P. Marcley
|
| Vol #:
|
| 9
|
|
|
| 2004D-0371
|
| Class II Special Controls Guidance Document: Serological Reagents for the Detection of Beta-Glucan
|
|
|
| GDL
1
|
| Guideline
|
| Vol #:
|
| 1
|
|
|
| NAD
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004N-0018
|
| Human Subject Protection; Foreign Clinical Studies Not Conducted Under an Investigational New Drug Application
|
|
|
| EMC 27
|
| B. Haire
|
| Vol #:
|
| 1
|
|
|
| 2004N-0330
|
| Suicidality in Clinical Trials for Antidepressant Drugs in Pediatric Patients
|
|
|
| EC 46
|
| NONE
|
| Vol #:
|
| 1
|
|
|
| EC 47
|
| Dr. Steven Klotz
|
| Vol #:
|
| 1
|
|